尔康制药 (300267.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(尔康制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 30.003.0023.0028.0023.0020.0020.0024.0025.00
 单季度销售净利率(%) --73.00-4.004.004.001.001.002.005.00
 单季度净资产收益率ROE(%) --5.00-1.001.00----
 单季度总资产净利率ROA(%) --4.00-------
单季度财务摘要:
 单季度营业总收入(元) 275,789,340.00337,752,189.00395,206,072.00503,235,051.00546,925,469.00553,152,635.00446,837,040.00444,203,454.00426,347,681.00
 单季度营业总成本(元) 288,330,694.00437,632,948.00424,350,554.00509,058,404.00525,219,145.00581,326,258.00452,282,220.00440,879,459.00407,517,432.00
 单季度营业收入(元) 275,789,340.00337,752,189.00395,206,072.00503,235,051.00546,925,469.00553,152,635.00446,837,040.00444,203,454.00426,347,681.00
 单季度营业利润(元) 838,833.00-242,542,207.00-12,779,569.0029,678,102.0018,917,823.00-31,733,705.005,119,117.0019,231,907.0021,162,595.00
 单季度利润总额(元) 748,003.00-240,239,266.00-12,359,982.0032,804,408.0020,861,989.00-31,737,454.008,034,344.0019,315,808.0021,741,497.00
 单季度净利润(元) -285,701.00-245,816,095.00-17,156,400.0020,663,218.0020,455,494.006,596,554.003,148,678.007,360,071.0019,785,501.00
 单季度归属母公司股东的净利润(元) 2,901,462.00-235,396,446.00-11,876,664.0025,871,810.0026,078,946.009,445,184.006,224,646.007,554,538.0022,533,578.00
 单季度经营活动产生的现金流量(元) 10,699,221.00171,053,825.00-73,984,312.00174,554,999.00-123,203,775.00134,416,167.0078,540,192.00-68,061,915.00136,125,499.00
 单季度投资活动产生的现金流量(元) -200,634,547.00-8,161,133.00-57,683,253.0010,161,031.00-49,235,087.00230,261,652.00-422,920,164.00204,234,214.00-270,159,931.00
 单季度筹资活动产生的现金流量(元) 154,886,859.0070,064,167.00-1,113,468.00-64,554,812.00-170,401,976.00-20,981,091.00-1,631,289.00-11,087,437.0024,331,603.00
 单季度现金及现金等价物净增加(元) -40,894,504.00235,490,603.00-135,205,340.00123,117,757.00-345,705,693.00342,376,231.00-339,846,609.00140,082,438.00-111,242,407.00

前瞻产业研究院